Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

In vitro antifungal susceptibility patterns of Trichophyton benhamiae complex isolates from diverse origin

F. Shamsizadeh, S. Ansari, A. Zarei Mahmoudabadi, V. Hubka, A. Čmoková, J. Guillot, A. Rafiei, K. Zomorodian, S. Nouripour-Sisakht, K. Diba, T. Mohammadi, H. Zarrinfar, A. Rezaei-Matehkolaei

. 2021 ; 64 (11) : 1378-1386. [pub] 20210425

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22003346

Grantová podpora
NV17-31269A MZ0 CEP - Centrální evidence projektů

BACKGROUND: Species from the Trichophyton benhamiae complex are mostly zoophilic dermatophytes which cause inflammatory dermatophytosis in animals and humans worldwide. OBJECTIVES: This study was purposed to (a) to identify 169 reference and clinical dermatophyte strains from the T benhamiae complex species by molecular method and adhering to the newest taxonomy in the complex (b) to evaluate the in vitro antifungal susceptibility profile of these strains against eight common and new antifungal agents that may be used for the treatment of dermatophytosis. METHODS: All isolates, mainly originated from Europe but also from Iran, Japan and USA, were subjected to ITS-rDNA sequencing. The in vitro antifungal susceptibility profiles of eight common and new antifungal drugs against the isolates were determined by CLSI M38-A2 protocol and according to microdilution method. RESULTS: Based on the ITS-rDNA sequencing, T benhamiae was the dominant species (n = 102), followed by T europaeum (n = 29), T erinacei (n = 23), T japonicum (n = 10), Trichophyton sp (n = 4) and T eriotrephon (n = 1). MIC ranges across all isolates were as follows: luliconazole: 0.0002-0.002 µg/ml, terbinafine: 0.008-0.125 µg/ml, efinaconazole: 0.008-0.125 µg/ml, ciclopirox olamine: 0.03-0.5 µg/ml, itraconazole: 0.06-2 µg/ml, griseofulvin: 0.25-4 µg/ml, amorolfine hydrochloride: 0.125-4 µg/ml and tavaborole: 1-16 µg/ml. CONCLUSION: Luliconazole, efinaconazole and terbinafine were the most potent antifungals against T benhamiae complex isolates, regardless of the geographic locations where strains were isolated. These data might help dermatologists to develop effective therapies for successful treatment of infections due to T benhamiae complex species.

000      
00000naa a2200000 a 4500
001      
bmc22003346
003      
CZ-PrNML
005      
20220127150322.0
007      
ta
008      
220113s2021 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1111/myc.13287 $2 doi
035    __
$a (PubMed)33864711
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Shamsizadeh, Forough $u Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran $u Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
245    10
$a In vitro antifungal susceptibility patterns of Trichophyton benhamiae complex isolates from diverse origin / $c F. Shamsizadeh, S. Ansari, A. Zarei Mahmoudabadi, V. Hubka, A. Čmoková, J. Guillot, A. Rafiei, K. Zomorodian, S. Nouripour-Sisakht, K. Diba, T. Mohammadi, H. Zarrinfar, A. Rezaei-Matehkolaei
520    9_
$a BACKGROUND: Species from the Trichophyton benhamiae complex are mostly zoophilic dermatophytes which cause inflammatory dermatophytosis in animals and humans worldwide. OBJECTIVES: This study was purposed to (a) to identify 169 reference and clinical dermatophyte strains from the T benhamiae complex species by molecular method and adhering to the newest taxonomy in the complex (b) to evaluate the in vitro antifungal susceptibility profile of these strains against eight common and new antifungal agents that may be used for the treatment of dermatophytosis. METHODS: All isolates, mainly originated from Europe but also from Iran, Japan and USA, were subjected to ITS-rDNA sequencing. The in vitro antifungal susceptibility profiles of eight common and new antifungal drugs against the isolates were determined by CLSI M38-A2 protocol and according to microdilution method. RESULTS: Based on the ITS-rDNA sequencing, T benhamiae was the dominant species (n = 102), followed by T europaeum (n = 29), T erinacei (n = 23), T japonicum (n = 10), Trichophyton sp (n = 4) and T eriotrephon (n = 1). MIC ranges across all isolates were as follows: luliconazole: 0.0002-0.002 µg/ml, terbinafine: 0.008-0.125 µg/ml, efinaconazole: 0.008-0.125 µg/ml, ciclopirox olamine: 0.03-0.5 µg/ml, itraconazole: 0.06-2 µg/ml, griseofulvin: 0.25-4 µg/ml, amorolfine hydrochloride: 0.125-4 µg/ml and tavaborole: 1-16 µg/ml. CONCLUSION: Luliconazole, efinaconazole and terbinafine were the most potent antifungals against T benhamiae complex isolates, regardless of the geographic locations where strains were isolated. These data might help dermatologists to develop effective therapies for successful treatment of infections due to T benhamiae complex species.
650    _2
$a zvířata $7 D000818
650    _2
$a antifungální látky $x farmakologie $x terapeutické užití $7 D000935
650    _2
$a Arthrodermataceae $x klasifikace $x účinky léků $x genetika $x izolace a purifikace $7 D003883
650    _2
$a lidé $7 D006801
650    _2
$a tinea $x farmakoterapie $x mikrobiologie $7 D014005
650    _2
$a zoonózy $x farmakoterapie $x mikrobiologie $7 D015047
651    _2
$a Evropa $7 D005060
651    _2
$a Írán $7 D007492
651    _2
$a Japonsko $7 D007564
651    _2
$a Spojené státy americké $7 D014481
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ansari, Saham $u Department of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
700    1_
$a Zarei Mahmoudabadi, Ali $u Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran $u Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
700    1_
$a Hubka, Vít $u Department of Botany, Faculty of Science, Charles University, Prague, Czech Republic $u Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology, Czech Academy of Sciences, Vídeňská, Czech Republic
700    1_
$a Čmoková, Adéla $u Department of Botany, Faculty of Science, Charles University, Prague, Czech Republic $u Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology, Czech Academy of Sciences, Vídeňská, Czech Republic
700    1_
$a Guillot, Jacques $u Dynamic Research Group UPEC, EnvA, USC Anses, Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France
700    1_
$a Rafiei, Abdollah $u Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran $u Department of Medical Parasitology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
700    1_
$a Zomorodian, Kamiar $u Department of Medical Mycology and Parasitology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
700    1_
$a Nouripour-Sisakht, Sadegh $u Medicinal Plant Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
700    1_
$a Diba, Kambiz $u Department of Medical Mycology and Parasitology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran
700    1_
$a Mohammadi, Tooba $u Department of Medical Mycology and Parasitology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
700    1_
$a Zarrinfar, Hossein $u Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
700    1_
$a Rezaei-Matehkolaei, Ali $u Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran $u Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
773    0_
$w MED00010272 $t Mycoses $x 1439-0507 $g Roč. 64, č. 11 (2021), s. 1378-1386
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33864711 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127150318 $b ABA008
999    __
$a ok $b bmc $g 1750961 $s 1154495
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 64 $c 11 $d 1378-1386 $e 20210425 $i 1439-0507 $m Mycoses $n Mycoses $x MED00010272
GRA    __
$a NV17-31269A $p MZ0
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...